Leucemia linfatica cronica - Epatite virale C

from Salute e Società · host Marco Caracciolo

1. Leucemia linfatica cronica, una nuova possibilità terapeutica per i pazienti è costituita da zanubrutinib, un inibitore di nuova generazione della tirosino-chinasi di Bruton. 2. Per una corretta gestione delle persone con epatite virale C sono state strutturate delle reti e dei link di collegamento tra la medicina generale e gli specialisti.

Episode metadata supplied by the publisher feed · Published Dec 9, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Leucemia linfatica cronica - Epatite virale C

0:00 6:52

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Salute e Società?

This episode is 6 minutes long.

When was this Salute e Società episode published?

This episode was published on December 9, 2023.

Can I download this Salute e Società episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!